Saturday, April 08, 2006


Viral Hepatitis C - Clinical Trial: Low-Dose Peginterferon and Ribavirin to Treat ...


Clinical Trial: Low-Dose Peginterferon and Ribavirin to Treat ...
This study will examine the effectiveness of low-dose peginterferon and ribavirin ... Drug: Peginterferon alfa-2a and ribavirin for chronic hepatitis C ...

NEJM -- Peginterferon Alfa-2a plus Ribavirin versus Interferon ...
Original Article from The New England Journal of Medicine -- Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic ...

MedlinePlus Drug Information: Peginterferon Alfa 2a ( Systemic)
Peginterferon alfa-2a is used to treat chronic hepatitis C. It is used for ... In deciding to use a medicine, the risks of using peginterferon alfa-2a must ...

NEJM -- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis ...
Original Article from The New England Journal of Medicine -- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected ...

Pegasys Online, Description, Chemistry, Ingredients ...
Alpha interferons, including PEGASYS (peginterferon alfa 2a), may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, ...

Friday, April 07, 2006


Peginterferon - A Summary of Chronic Hepatitis C InfectionHepatitis C

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Thursday, April 06, 2006


Peginterferon - PBS - Who Cares: Chronic Illness in America -- Hepatitus C


PBS - Who Cares: Chronic Illness in America -- Hepatitus C
... Previous Next. Resources. Chronic Hepatitis C: Current Disease Management ...

What Is Hepatitis C
... This is called "chronic hepatitis C infection." Chronic hepatitis C infection usually progresses slowly ... In some cases chronic hepatitis C causes only mild symptoms ...

Chronic hepatitis C, depression and interferon
Hepatitis C Articles (HCV) Chronic hepatitis C, depression and interferon. Journal of Hepatology. June 2005 ... associated with the current treatment of chronic hepatitis C (HCV): depression [1,2]. It is ... associated depression in psychiatric risk patients with chronic hepatitis C. J Hepatol ...

Chronic Hepatitis C Symptoms
Info about chronic hepatitis C and its most common symptoms. Hepatitis C is the most common liver disease currently seen in clinical practice. Symptoms of Chronic Hepatitis C: chronic viral hepatitis may be very subtle and no more than a mild ... HEPATITIS C SYMPTOMS, CHRONIC HEPATITIS C SYMPTOMS, TREATMENT, INFO ABOUT HEP C VIRUS, HERBS ...

chronic hepatitis c
Patient medical question and doctor answer from The Hepatitis Forum. Health topic area and articles about hepatitis c Topics: . ... Topic: Hepatitis C. Subject: chronic hepatitis c. i was diagnosed with hepatitis c several years ago ...

TAG: Hepatitis C Virus (HCV) and HIV/HCV Coinfection
... of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection ... progression of liver damage of chronic hepatitis C patients and correlates with ...

Viral Hepatitis C - County Council to examine controversial needle exchange program


County Council to examine controversial needle exchange program
Pittsburgh Post-Gazette - Yesterday, more than 100 people walked through the parking lot of the Allegheny County Health Department, entered one of the building's narrow hallways, and got fresh supplies of the alcohol swabs, syringes and needles they need to inject illegal

Safety of blood supply a concern
Lexington Herald-Leader - ST. LOUIS - The first people hurt when the nation's blood supply gets tainted are likely to be those whose lives depend on transfusions. That's why blood safety is a major concern of the more than 400 people with hemophilia and other clotting

Researchers look for hepatitis C vaccine
News 14 Raleigh / Durham - (ST. LOUIS) - It's been called the silent epidemic. Four million Americans now live with it, and there's no cure. As many as 200 million people around the world have hepatitis C, and researchers expect that number to triple in the next decade. The

Escovedo's 'Hand' Resonates With Immigration Debate
Billboard - Barry A. Jeckell, N.Y. Alejandro Escovedo recently discovered that the music he wrote for the play "By the Hand of the Father" has continuing resonance, especially as it relates to the ongoing immigration debate in the U.S. Congress. Escovedo's songs

Regulations are filed for medical marijuana plan
Providence Business News - The R.I. Department of Health has taken steps to implement the Medical Marijuana Program as directed by the General Assembly. The Edward O. Hawkins and Thomas C. Slater Medical Marijuana Act was enacted earlier this year on Jan. 3. The regulations

Wednesday, April 05, 2006


Viral Hepatitis C - Enzo Biochem Initiates Phase II Trial of Immunomodulatory Compound ...


Enzo Biochem Initiates Phase II Trial of Immunomodulatory Compound ...
Genetic Engineering News, NY - Mar 14, 2006... of its proprietary gene medicine for HIV-1 infection and its proprietary immune regulation medicines for hepatitis B and hepatitis C infection and for Crohn's ...

Human Genome Sciences Reports Positive Interim Results of Phase 2 ...
PR Newswire (press release), NY - Mar 14, 2006... Human Genome Sciences is developing Albuferon for use in the treatment of chronic hepatitis C. Hepatitis C infection is an inflammation of the liver caused by ...

The needle-exchange program: This is 'success'?
Pittsburgh Tribune-Review, PA - Mar 23, 2006... And since determining when the hepatitis C infection occurred is difficult, quantifying the program's effectiveness is nearly impossible. ...

Stocks to Watch: Peregrine Pharmaceuticals
New Age Media Concepts (press release) - Mar 30, 2006Their portfolio consist of Tarvacin Anti-Viral is in Phase I studies for hepatitis C infection pre-clinical studies in influenza, Tarvacin Anti-Cancer is in a ...

Needle exchange coming to town
KSBY, CA - Mar 9, 2006... and running. An exchange center can lower HIV and Hepatitis C infection rates, which are transmitted through sharing needles. The ...

Tuesday, April 04, 2006


Peginterferon - Rally for Hepatitis Awareness


Rally for Hepatitis Awareness
The Hepatitis C Movement for Awareness (HMA) is once again planning a march in Washington DC to promote the need for an awareness campaign. See how you can take part even if you cannot join the march to the White...

Liver Cancer, Hepatitis C Connection Gets Clearer
Title: Liver Cancer, Hepatitis C Connection Gets ClearerCategory: Health NewsCreated: 12/8/2005 1:59:00 AMLast Editorial Review: 12/8/2005 1:58:50 AM

MedMira Rapid Test
The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity....

A Good AASLD Meeting Summary
This is a terrific overview article regarding the AASLD meeting. Liz Highleyman did a fantastic job of condensing the key aspects and announcements. One of the most interesting updates/corrections of known information is the upward measurement of the number of...

Vitamins Suggested During Combination Therapy
A Japanese research study demonstrates benefits of Vitamin E and C supplementation during combination therapy. These vitamins appear to protect cells from damage typically incurred from conventional Hepatitis C therapy....

Monday, April 03, 2006


Peginterferon - Vitamins Suggested During Combination Therapy


Vitamins Suggested During Combination Therapy
A Japanese research study demonstrates benefits of Vitamin E and C supplementation during combination therapy. These vitamins appear to protect cells from damage typically incurred from conventional Hepatitis C therapy....

Alcoholism Facts
Title: Alcoholism FactsCategory: Health FactsCreated: 8/9/2005Last Editorial Review: 8/29/2005

Viral Hepatitis
Title: Viral HepatitisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/5/2005

Hepatitis C Patients Taxing Medical System
Title: Hepatitis C Patients Taxing Medical SystemCategory: Health NewsCreated: 12/31/2005 1:59:00 AMLast Editorial Review: 12/31/2005 1:58:37 AM